Chimeric antigen receptor (CAR) T cells represent a major advance for immunotherapy. However, while CAR T cell approaches against liquid tumors have been successful, results against solid tumors are less promising.
Download this white paper from Sartorius to learn more about how to phenotype and assess the function of CAR-modified immune cells, including T cells, NK cells, and macrophages.
Never miss an email from The Scientist. Click hereto add The Scientist to your safe-sender list.
The Scientist,1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll-Free: (888) 781-0328 | Phone: (705) 528-6888 Email: privacy@the-scientist.com